Vax Before Cancer

 / October 25th, 2021

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Oct 19 • 7:25 pm CDT
California-based ImmunityBio, Inc. announced that Papillary disease (Cohort B), the second indication of its QUILT 3.032 Phase 2/3 study of intravesical BCG plus Anktiva in patients with BCG-unresponsive high-grade NMIBC, also met its primary endpoints with...
Oct 14 • 1:27 pm CDT
Oesophageal cancer cases have tripled in under the 50s age group over the past 30 years, a new study presented at UEG Week Virtual 2021 has found. The dramatic increases were seen in patients with oesophageal...
Oct 13 • 3:52 pm CDT
The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Verzenio® (abemaciclib), in combination with endocrine therapy (tamoxifen or an aromatase inhibitor), for the adjuvant treatment of adult patients with hormone receptor-positive (HR+), human...
Sep 29 • 1:13 pm CDT
New York-based Regeneron Pharmaceuticals, Inc. announced on September 28, 2021, the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental Biologics License Application (sBLA) for PD-1 inhibitor Libtayo® (cemiplimab-rwlc) to treat patients...
Sep 28 • 4:28 pm CDT
California-based Nonagen Bioscience Corp today announced Oncuria™, their non-invasive bladder cancer test capable of predicting response to therapy, has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation. This FDA designation is granted to...

For more articles, try our search.